HYCAMTIN 0.25 mg (Hycamtin 0.25 mg)
Generic Name: topotecan
This pill with imprint "HYCAMTIN 0.25 mg" is White, Capsule-shape and has been identified as Hycamtin 0.25 mg. It is supplied by GlaxoSmithKline.
Hycamtin is used in the treatment of ovarian cancer; small cell lung cancer; cancer; cervical cancer and belongs to the drug class miscellaneous antineoplastics. There is positive evidence of human fetal risk during pregnancy. Hycamtin 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Hycamtin
- Generic Name:
- topotecan
- Imprint:
- HYCAMTIN 0.25 mg
- Strength:
- 0.25 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antineoplastics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- GlaxoSmithKline
- Inactive Ingredients:
- glyceryl monostearate
gelatin
titanium dioxide
Note: Inactive ingredients may vary.
More about Hycamtin (topotecan)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Generic Availability
- Drug class: miscellaneous antineoplastics
Consumer resources
- Hycamtin (Topotecan Capsules)
- Hycamtin (Topotecan Injection)
- Hycamtin
- Hycamtin (Advanced Reading)
- Hycamtin Intravenous (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
